Analysts Set Mobia Medical, Inc. (NASDAQ:MOBI) PT at $20.25

Shares of Mobia Medical, Inc. (NASDAQ:MOBIGet Free Report) have earned an average rating of “Moderate Buy” from the six ratings firms that are covering the stock, MarketBeat.com reports. One research analyst has rated the stock with a hold rating and five have given a buy rating to the company. The average 12-month price objective among analysts that have updated their coverage on the stock in the last year is $20.25.

Several research analysts recently weighed in on MOBI shares. JPMorgan Chase & Co. started coverage on shares of Mobia Medical in a research note on Tuesday, June 2nd. They issued an “overweight” rating and a $15.00 target price for the company. BTIG Research assumed coverage on shares of Mobia Medical in a research report on Tuesday, June 2nd. They issued a “buy” rating and a $19.00 price objective for the company. Bank of America assumed coverage on shares of Mobia Medical in a research note on Tuesday, June 2nd. They set a “buy” rating and a $16.00 price objective on the stock. Wolfe Research initiated coverage on shares of Mobia Medical in a research report on Tuesday, June 2nd. They set an “outperform” rating on the stock. Finally, Zacks Research upgraded Mobia Medical to a “hold” rating in a report on Wednesday, June 3rd.

Get Our Latest Analysis on MOBI

Insider Buying and Selling at Mobia Medical

In other Mobia Medical news, insider Chase C. Leavitt purchased 3,000 shares of the firm’s stock in a transaction that occurred on Monday, May 11th. The stock was purchased at an average cost of $15.00 per share, with a total value of $45,000.00. Following the transaction, the insider owned 3,000 shares in the company, valued at approximately $45,000. This trade represents a ∞ increase in their ownership of the stock. The acquisition was disclosed in a legal filing with the SEC, which can be accessed through this link. Also, CFO Nelson Bunker Curnes bought 5,000 shares of the company’s stock in a transaction that occurred on Tuesday, June 9th. The shares were bought at an average price of $12.79 per share, for a total transaction of $63,950.00. Following the completion of the acquisition, the chief financial officer owned 366,997 shares in the company, valued at approximately $4,693,891.63. This trade represents a 1.38% increase in their position. The SEC filing for this purchase provides additional information. Over the last ninety days, insiders have acquired 1,273,332 shares of company stock valued at $19,088,930.

Mobia Medical Stock Down 1.9%

MOBI opened at $10.85 on Wednesday. Mobia Medical has a 12 month low of $10.19 and a 12 month high of $15.29. The firm has a market cap of $360.75 million, a PE ratio of -0.56 and a beta of 2.84. The company has a 50 day simple moving average of $12.84.

Mobia Medical (NASDAQ:MOBIGet Free Report) last announced its quarterly earnings results on Thursday, June 4th. The company reported ($19.30) earnings per share (EPS) for the quarter. The firm had revenue of $12.07 million for the quarter.

See Also

Analyst Recommendations for Mobia Medical (NASDAQ:MOBI)

Receive News & Ratings for Mobia Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Mobia Medical and related companies with MarketBeat.com's FREE daily email newsletter.